Page 132 - GPD-3-2

Gene & Protein in Disease Bioinformatics to identify gene signatures of CF

Availability of data doi: 10.3389/fphar.2018.01429

Dataset GSE70442 can be accessible through the GEO 11. Cheng SH, Gregory RJ, Marshall J, et al. Defective intracellular
database, https://www.ncbi.nlm.nih.gov/geo transport and processing of CFTR is the molecular basis of
most cystic fibrosis. Cell. 1990;63(4):827-834.
Further disclosure doi: 10.1016/0092-8674(90)90148-8
A preprint version of this article is available at Research 12. Farinha CM, King-Underwood J, Sousa M, et al. Revertants,
Square (https://doi.org/10.21203/rs.3.rs-3031398/v1). low temperature, and correctors reveal the mechanism of
F508del-CFTR rescue by VX-809 and suggest multiple
References agents for full correction. Chem Biol. 2013;20(7):943-955.

1. Schaffer K. Epidemiology of infection and current guidelines doi: 10.1016/j.chembiol.2013.06.004
for infection prevention in cystic fibrosis patients. J Hosp 13. Capurro V, Tomati V, Sondo E, et al. Partial rescue of
Infect. 2015;89(4):309-313. f508del-cftr stability and trafficking defects by double
2. Guo J, Garratt A, Hill A. Worldwide rates of diagnosis corrector treatment. Int J Mol Sci. 2021;22(10):5262.
and effective treatment for cystic fibrosis. J Cyst Fibros. doi: 10.3390/ijms22105262
2022;21(3):456-462.
14. Esposito C, Kamper M, Trentacoste J, Galvin S, Pfister H,
doi: 10.1016/j.jcf.2022.01.009 Wang J. Advances in the cystic fibrosis drug development
pipeline. Life. 2023;13(9):1835.
3. Stephenson AL, Stanojevic S, Sykes J, Burgel PR. The
changing epidemiology and demography of cystic fibrosis. doi: 10.3390/life13091835
Presse Med. 2017;46(6 Pt 2):e87-e95.
15. Levy H, Jia S, Pan A, et al. Identification of molecular
doi: 10.1016/j.lpm.2017.04.012 signatures of cystic fibrosis disease status with plasma-based
functional genomics. Physiol Genomics. 2019;51(1):27-41.
4. Burgel PR, Burnet E, Regard L, Martin C. The changing
epidemiology of cystic fibrosis. Chest. 2023;163(1):89-99. doi: 10.1152/physiolgenomics.00109.2018
doi: 10.1016/j.chest.2022.07.004 16. Wei T, Sui H, Su Y, et al. Research advances in molecular
mechanisms underlying the pathogenesis of cystic fibrosis:
5. Abubakar Bobbo K, Ahmad U, Chau DM, Nordin N, From technical improvement to clinical applications
Abdullah S. A comprehensive review of cystic fibrosis in (Review). Mol Med Rep. 2020;22(6):4992-5002.
Africa and Asia. Saudi J Biol Sci. 2023;30(7):103685.
doi: 10.3892/mmr.2020.11607
doi: 10.1016/j.sjbs.2023.103685
17. Oany AR, Mia M, Pervin T, Hasan MN, Hirashima A.
6. Strandvik B. Fatty acid metabolism in cystic fibrosis. N Engl Identification of potential drug targets and inhibitor of the
J Med. 2004;350(6):605-607. pathogenic bacteria Shigella flexneri 2a through the subtractive
doi: 10.1056/nejme038217 genomic approach. In Silico Pharmacol. 2018;6(1):11.
7. Castellani S, Di Gioia S, di Toma L, Conese M. Human doi: 10.1007/s40203-018-0048-2
cellular models for the investigation of lung inflammation 18. Oany AR, Mia M, Pervin T, Junaid M, Hosen SMZ,
and mucus production in cystic fibrosis. Anal Cell Pathol Moni MA. Design of novel viral attachment inhibitors of the
(Amst). 2018;2018:3839803. spike glycoprotein (S) of severe acute respiratory syndrome
doi: 10.1155/2018/3839803 coronavirus-2 (SARS-CoV-2) through virtual screening and
dynamics. Int J Antimicrob Agents. 2020;56(6):106177.
8. Rommens JM. Identification of the cystic fibrosis gene:
Chromosome walking and jumping. Trends Genet. doi: 10.1016/j.ijantimicag.2020.106177
1989;5(C):363. 19. Oany AR, Mia M, Pervin T, Alyami SA, Moni MA. Integrative
doi: 10.1016/0168-9525(89)90154-6 systems biology approaches to identify potential biomarkers
and pathways of cervical cancer. J Pers Med. 2021;11(5):363.
9. Balloy V, Varet H, Dillies MA, et al. Normal and cystic
fibrosis human bronchial epithelial cells infected with doi: 10.3390/jpm11050363
Pseudomonas aeruginosa exhibit distinct gene activation 20. Oany AR, Pervin T, Moni MA. Pharmacoinformatics based
patterns. PLoS One. 2015;10(10):e0140979. elucidation and designing of potential inhibitors against
doi: 10.1371/journal.pone.0140979 Plasmodium falciparum to target importin α/β mediated
nuclear importation. Infect Genet Evol. 2021;88:104699.
10. Awatade NT, Wong SL, Hewson CK, et al. Human primary
epithelial cell models: Promising tools in the era of cystic doi: 10.1016/j.meegid.2020.104699
fibrosis personalized medicine. Front Pharmacol. 2018;9:1429. 21. Oany AR, Pervin T, Mia M, et al. Vaccinomics approach for

Volume 3 Issue 2 (2024) 9 doi: 10.36922/gpd.2937